Cybersecurity is the number one topic that keeps boards and executives up at night. Threats of all kinds – from nation states to organized crime – are eager to steal the most valuable information and hold your company ransom, among other cyber threats. 

In our fourth episode of BioDech, Brenda Sharton, partner and Chair of Dechert’s top ranked, global Privacy & Cybersecurity practice, and Sophie Pelé, a Life Sciences Regulatory partner, are joined by guest speakers John Ansbach, Managing Director, Engagement Management at Stroz Friedberg, and Zoe Philippides, SVP, Chief Ethics, Compliance & Privacy Officer & Global Head of Litigation at Moderna to discuss major developments on the threat landscape, how to proactively respond to any potential threats, and how to ensure your company’s cybersecurity preparations can withstand the scrutiny of due diligence, especially when readying itself for an IPO.